BR9503876A - Quinoxalina-2,3-diona-oxa-ou tec-alifaticamente ligada em ponte processo para sua preparação compostos uso dos mesmos e composições farmacêuticas - Google Patents

Quinoxalina-2,3-diona-oxa-ou tec-alifaticamente ligada em ponte processo para sua preparação compostos uso dos mesmos e composições farmacêuticas

Info

Publication number
BR9503876A
BR9503876A BR9503876A BR9503876A BR9503876A BR 9503876 A BR9503876 A BR 9503876A BR 9503876 A BR9503876 A BR 9503876A BR 9503876 A BR9503876 A BR 9503876A BR 9503876 A BR9503876 A BR 9503876A
Authority
BR
Brazil
Prior art keywords
techno
quinoxaline
oxa
dione
pharmaceutical compositions
Prior art date
Application number
BR9503876A
Other languages
English (en)
Inventor
Robert Moretti
Kaspar Zimmermann
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of BR9503876A publication Critical patent/BR9503876A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
BR9503876A 1994-09-01 1995-08-31 Quinoxalina-2,3-diona-oxa-ou tec-alifaticamente ligada em ponte processo para sua preparação compostos uso dos mesmos e composições farmacêuticas BR9503876A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH268094 1994-09-01
CH40295 1995-02-09

Publications (1)

Publication Number Publication Date
BR9503876A true BR9503876A (pt) 1996-09-17

Family

ID=25684470

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9503876A BR9503876A (pt) 1994-09-01 1995-08-31 Quinoxalina-2,3-diona-oxa-ou tec-alifaticamente ligada em ponte processo para sua preparação compostos uso dos mesmos e composições farmacêuticas

Country Status (12)

Country Link
EP (1) EP0705835A1 (pt)
JP (1) JPH08109185A (pt)
KR (1) KR960010651A (pt)
CN (1) CN1133844A (pt)
AU (1) AU3028795A (pt)
BR (1) BR9503876A (pt)
CA (1) CA2157231A1 (pt)
FI (1) FI954072A (pt)
HU (1) HUT73436A (pt)
IL (1) IL115103A0 (pt)
NO (1) NO953420L (pt)
NZ (1) NZ272888A (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6063774A (en) * 1996-12-16 2000-05-16 Warner-Lambert Company Tricyclic quinoxaline derivatives as neuroprotective agents
FR2760237B1 (fr) * 1997-02-28 1999-04-16 Rhone Poulenc Rorer Sa Thiazolobenzoheterocycles, leur preparation et les medicaments les contenant
US6288075B1 (en) 1998-02-26 2001-09-11 Rhone-Poulenc Rorer S.A. Thiazolo[5,4,3-ij]quinolines, preparation and medicines containing the same
FR2766487B1 (fr) * 1997-07-28 1999-08-27 Rhone Poulenc Rorer Sa Thiazolobenzoheterocycles, leur preparation et les medicaments les contenant
US20100074949A1 (en) 2008-08-13 2010-03-25 William Rowe Pharmaceutical composition and administration thereof
BR122018075478B8 (pt) 2004-06-24 2023-10-31 Vertex Pharma moduladores de transportadores de cassete de ligação de atp
US8354427B2 (en) 2004-06-24 2013-01-15 Vertex Pharmaceutical Incorporated Modulators of ATP-binding cassette transporters
HUE049976T2 (hu) 2005-12-28 2020-11-30 Vertex Pharma N-[2,4-bisz(1,1-dimetil-etil)-5-hidroxi-fenil]-1,4-dihidro-4-oxo-kinolin-3-karboxamid amorf alakjának gyógyászati kompozíciói
SG10201504084QA (en) 2009-03-20 2015-06-29 Vertex Pharma Process for making modulators of cystic fibrosis transmembrane conductance regulator
US8802700B2 (en) 2010-12-10 2014-08-12 Vertex Pharmaceuticals Incorporated Modulators of ATP-Binding Cassette transporters
CN109966264A (zh) 2012-02-27 2019-07-05 沃泰克斯药物股份有限公司 药物组合物及其施用
CN107250113B (zh) 2014-10-07 2019-03-29 弗特克斯药品有限公司 囊性纤维化跨膜传导调节蛋白的调节剂的共晶

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK716188D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Quinoxalinforbindelser, deres fremstilling og anvendelse
DK715888D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Quinoxalinforbindelser, deres fremstilling og anvendelse
JP2955358B2 (ja) * 1989-06-09 1999-10-04 ファルマシア・アンド・アップジョン・カンパニー 中枢神経系活性を有する複素環系アミン
JPH05117276A (ja) * 1991-10-23 1993-05-14 Sumitomo Pharmaceut Co Ltd 新規な３環性キノキサリンジオン誘導体
AU672617B2 (en) * 1992-06-22 1996-10-10 Regents Of The University Of California, The Glycine receptor antagonists and the use thereof
ES2109516T3 (es) * 1992-10-13 1998-01-16 Warner Lambert Co Derivados de quinoxalinodiona como antagonistas de aminoacidos excitadores.
US5631373A (en) * 1993-11-05 1997-05-20 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones

Also Published As

Publication number Publication date
HUT73436A (en) 1996-07-29
NO953420D0 (no) 1995-08-31
IL115103A0 (en) 1995-12-08
NZ272888A (en) 1997-05-26
FI954072A (fi) 1996-03-02
JPH08109185A (ja) 1996-04-30
AU3028795A (en) 1996-03-14
CN1133844A (zh) 1996-10-23
HU9502562D0 (en) 1995-10-30
KR960010651A (ko) 1996-04-20
CA2157231A1 (en) 1996-03-02
NO953420L (no) 1996-03-04
EP0705835A1 (de) 1996-04-10
FI954072A0 (fi) 1995-08-30

Similar Documents

Publication Publication Date Title
BR9504509A (pt) Composto processo para sua preparaçao e formulaçao farmaceûtica
BR9501770A (pt) Uso de um composto,composto,formulação farmacêutica e processo para preparar um composto
BR9506561A (pt) Co-grânulo homogêneo composição detergente tablete de detergente processos para sua preparação e uso dos mesmos
BR9611986A (pt) Compostos processo para a preparação dos mesmos composição farmcéutica e utilização dos compostos
BR9202653A (pt) Derivados de 3-aril-4-hidroxi-delta3-dihidrofuran ona e derivados de 3-aril-4-hidroxi-delta-dihidrotiofenona,processo para sua preparacao,composicoes inseticidas,processo para o combate de insetos,emprego e processo para a preparacao de composicoes
BR9000631A (pt) Compostos contendo grupos nitro,processo para sua preparacao,composicoes inseticidas,processo para sua preparacao e processo para o combate de insetos nocivos
BR0017030B1 (pt) derivados de tiazolilamida, processo para sua preparação, composição farmacêutica que os compreende e uso dos mesmos
EE9500064A (et) Asendatud 1H-imidasoolid, nende valmistamismeetodid ja farmatseutilised kompositsioonid
BR9201657A (pt) Compostos derivados aromaticos aminados,processo para a preparacao dos mesmos e composicao farmaceutica
BR9004852A (pt) Composto,processo para sua preparacao,sua aplicacao e composicao farmaceutica
BR9711311B1 (pt) derivado de 1,2,3,4-tetrahidroquinolina, composiÇço farmaceutica, uso de um derivado de 1,2,3,4-tetrahidroquinolina, e, processo para a preparaÇço de compostos.
BR9710739B1 (pt) polissacarÍdeos sintÉticos, processo para sua preparaÇço, composiÇÕes farmacÊuticas que os contÊm e utilizaÇço dos mesmos.
BR9503876A (pt) Quinoxalina-2,3-diona-oxa-ou tec-alifaticamente ligada em ponte processo para sua preparação compostos uso dos mesmos e composições farmacêuticas
BR9506106A (pt) Composto processo para sua preparação medicamento e composição farmacêutica
BR9600339A (pt) Compostos composições farmacêuticas processo para a preparação de um composto e uso dos mesmos
BR9602025A (pt) Composto composição farmacêutica uso e processo para a preparação de um composto
BR1100524A (pt) Compostos, processo para sua preparação; compostos intermediários para os mesmos, e composições farmacêuticas
EE03996B1 (et) Farmatseutilised kompositsioonid, nende valmistamismeetod ja kasutamine
BR9002805A (pt) Derivados de 2-acilamino-4-halogeno-5-nitrotiazol,processo para a sua preparacao,sua aplicacao,composicao praguicida,processo para sua preparacao,processo para combater pragas,derivados de 4-halogeno-2-halogenocarbonilamino-5-nitrotiazol,processo para sua preparacao e sua aplicacao
PT939083E (pt) Complexos de ferro-succinilcaseina procedimento para sua preparacao e suas composicoes farmaceuticas
BR9506062A (pt) Compostos processo para sua preparação medicamento e composição farmacêutica
BR9302359A (pt) Composto,processo para sua preparacao,medicamento e uso
BR9710215A (pt) Composto processo para sua preparação e formulação farmacéutica
BR9503458A (pt) Quinoxalina-2,3-diona azaalifaticamente ligada em ponte processo para sua preparaçao compostos composiçao farmacêutica e usos dos compostos
BR9300250A (pt) Composto,processo para sua preparacao,medicamento e uso

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law